0001707040-17-000001.txt : 20170519 0001707040-17-000001.hdr.sgml : 20170519 20170519104936 ACCESSION NUMBER: 0001707040-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170519 DATE AS OF CHANGE: 20170519 EFFECTIVENESS DATE: 20170519 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Respirogen, Inc. CENTRAL INDEX KEY: 0001707040 IRS NUMBER: 815155189 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-287116 FILM NUMBER: 17856747 BUSINESS ADDRESS: STREET 1: 1880 SOUTH FLATIRON COURT STREET 2: SUITE H2 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 303-906-1100 MAIL ADDRESS: STREET 1: 1880 SOUTH FLATIRON COURT STREET 2: SUITE H2 CITY: BOULDER STATE: CO ZIP: 80301 D 1 primary_doc.xml X0707 D LIVE 0001707040 Respirogen, Inc. 5757 Central Avenue Suite B BOULDER CO COLORADO 80301 720-749-2733 DELAWARE None None Corporation true 2017 Robert Scribner 5757 Central Avenue Suite B Boulder CO COLORADO 80301 Executive Officer Director Paul Mountford 5757 Central Avenue Suite B Boulder CO COLORADO 80301 Executive Officer Director Mark Borden 5757 Central Avenue Suite B Boulder CO COLORADO 80301 Executive Officer Director Other Technology Decline to Disclose 06b false 2017-02-06 false true false 0 100000 15000 85000 false 1 0 0 0 false Respirogen, Inc. /S/ Robert Scribner Robert Scribner CEO, By Chris Ingvalson, Attorney-In-Fact 2017-05-19